VetDB wins investment from global biopharma

Ross Wyness - Steve Joslyn - ChantelConcei
Ross Wyness (left) and Steve Joslyn from VetDB. Photo - Chantel Concei.

VetDB has snagged an investment from global biopharma MSD Animal Health, a division of Merck & Co Inc, Kenilworth, New Jersey, USA (NYSE: MRK).

MSD Animal Health joins VetDB’s existing investors in VetDB’s third round of seed funding.

VetDB’s uses RFID technology to lock medical information to an animal’s unique microchip, while MSD Animal Health has an impressive portfolio of digital identification products (both readers and microchips). MSD Animal Health also boasts a diverse vaccine portfolio, while VetDB technology has been developed to record and manage accurate vaccination data.

A global leader in veterinary health care, the US-based MSD Animal Health has been bringing forward medicines and vaccines for many of the world’s most challenging diseases over its 130 years history.

Being backed by a company like MSD Animal Health tells us that our new technology – which helps automate important processes like vaccination tracking, pathology testing and data storage – is the future of our industry.

Dr Steve Joslyn, co-Founder of VetDB

The capital from this latest funding round, including the MSD Animal Health investment, will be used to fuel VetDB’s continued growth and the nationwide rollout of its medical technology.

“We’ve already seen the success of this technology when deployed in veterinary practices in Western Australia,” said David Hallas, leader of Sure PetCare, a business unit of MSD Animal Health. “We believe it could significantly improve data accuracy and health-record management, and we look forward to working with VetDB and building on their achievements.”

Originally formed as an idea at a Startup Weekend many years ago, Dr Steve Joslyn has been working away building up the business ever since.

VetDB screenshot.

“It’s a perfect alignment for us, as MSD Animal Health and VetDB are both dedicated to pioneering solutions to improve animal health in farm animals and pets,” he added.

“It’s hard not to see the synergies and the exciting opportunities with this latest investment,” said Dr Joslyn.


For more information, visit